The numbers are in and they are grim. There are 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths from Clostridium difficile infections that are healthcare-acquired in the United States ...
Verywell Health on MSN
What to eat when you have C diff (Clostridioides difficile)
Medically reviewed by Lindsey Waldman, MD, RD Key Takeaways Eat foods with probiotics like yogurt and kefir to help replenish ...
Clostridium difficile, or C. diff— a potentially deadly bacterial infection that’s gained attention due to its treatment by fecal transplants— occurs when the body’s natural balance of gut bacteria ...
A study presented by Mayo Clinic researchers during Digestive Disease Week 2012 provides clear evidence that the number of people contracting the hard-to-control and treat bacterial infection ...
The C Diff Foundation announces the release of a nutritional guide, "Nutrition; Managing Meals through a C. difficile Infection" (ISBN: 978-1973304241) authored by Nancy C. Caralla, C Diff ...
Researchers have identified what Clostridium difficile toxin causes disease in humans. The study reveals that for decades researchers have been focusing on the wrong toxin that is released by the ...
Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Local physician Dr. Richard Mills is researching a vaccine that could prevent C. diff, a dangerous ...
Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide SWIFTWATER, Pa., Aug. 5, 2013 /PRNewswire/ -- Sanofi Pasteur, the vaccines ...
WASHINGTON – March is the month when hospitals see more Clostridium difficile infections, and the Northeast is the region that leads the nation in the difficult to treat infection, researchers ...
PORT HUENEME, CA--(Marketwired - Oct 28, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today the presentation of a preclinical poster ...
Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback